ANI is a Minnesota-based biopharmaceutical company that develops and commercializes generic prescription medicines for the treatment of cancer disease.
Business Model:
Revenue: $283.1M
Employees: 501-1,000
ANI was acquired by
Meridian Venture Partners.
The acquisition happend on 2004-04-12.
Details of the transaction were not public
Address: 210 Main Street West
City: Baudette
State: MN
Zip: 56623
Country: US
ANI is a Minnesota-based biopharmaceutical company that develops and commercializes generic prescription medicines for the treatment of cancer disease.
Contact Phone:
+12186343500
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/10/2000
Ticker Symbol:
ANIP
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2010 | IPO | - | 11/2021 | Post-IPO Equity | $75M | 12/2017 | Post-IPO Debt | 1 | $125M |
Citizens Bank Citizens Bank Citizens Bank Citizens Bank |
3/2010 | IPO | - |
---|
Announced Date | Name | Price |
---|---|---|
3/2021 | Novitium Pharma | |
8/2018 | WellSpring Pharma Services | |
10/2012 | BioSante Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|